Targeted deletion of HGFL in mice impairs RON-driven breast tumorigenesis, metastatic progression, and restores anti-tumor CD8 T-cell function, supporting an important role for ligand-dependent RON signaling in oncogenic RON activation even in the context of RON overexpression [5]. Here, CD8A is linked to neoplasm.